Cancer resistance via the downregulation of the tumor suppressors <i>RKIP</i> and <i>PTEN</i> expressions: therapeutic implications.

Moghaddam, Matthew; Vivarelli, Silvia; Falzone, Luca; Libra, Massimo; Bonavida, Benjamin

Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications.

Moghaddam, Matthew; Vivarelli, Silvia; Falzone, Luca; Libra, Massimo; Bonavida, Benjamin.

Afiliação

Moghaddam M; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles (UCLA), East Los Angeles, CA 90095, USA.
Vivarelli S; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Occupational Medicine Section, University of Messina, 98125 Messina, Italy.
Falzone L; Epidemiology and Biostatistics Unit, National Cancer Institute IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
Libra M; Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
Bonavida B; Research Centre for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy.

Explor Target Antitumor Ther ; 4(2): 170-207, 2023.

Article em En | MEDLINE | ID: mdl-37205308

Palavras-chave

PTEN; RKIP; bioinformatics; cross-talks; resistance; signaling

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Explor Target Antitumor Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google